Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000168

EVP, Chief Reg. & Quality Off. sold 2,175 shares at $460.00 ($1,000,500)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Tatsis Ourania · EVP, Chief Reg. & Quality Off.

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-06-03 Sale : show line 1 in the form 10b5-1 −2,175 $460.00 $1,000,500 49,098 D
Open-market sales · 2,175 sh · avg $460.00 · $1,000,500
Loading xslF345X05/wk-form4_1717618128.xml…